Enovis Corp. (ENOV)
25.32
+0.22
(+0.88%)
USD |
NYSE |
Apr 15, 16:00
25.32
0.00 (0.00%)
After-Hours: 20:00
Enovis Research and Development Expense (Annual) : 120.33M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Integra LifeSciences Holdings Corp. | 34.81M |
| Globus Medical, Inc. | 146.94M |
| Abbott Laboratories | 2.889B |
| Accuray, Inc. | 47.94M |
| Plus Therapeutics, Inc. | 8.379M |